OptimizeRx (OPRX) Receivables Refunds (2023 - 2025)
Historic Receivables Refunds for OptimizeRx (OPRX) over the last 3 years, with Q3 2025 value amounting to $1.7 million.
- OptimizeRx's Receivables Refunds rose 262968.75% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 262968.75%. This contributed to the annual value of $1.0 million for FY2023, which is N/A changed from last year.
- Per OptimizeRx's latest filing, its Receivables Refunds stood at $1.7 million for Q3 2025, which was up 262968.75% from $646000.0 recorded in Q2 2025.
- In the past 5 years, OptimizeRx's Receivables Refunds registered a high of $1.8 million during Q2 2024, and its lowest value of $64000.0 during Q3 2024.
- In the last 3 years, OptimizeRx's Receivables Refunds had a median value of $1.0 million in 2023 and averaged $926285.7.
- Over the last 5 years, OptimizeRx's Receivables Refunds had its largest YoY gain of 262968.75% in 2025, and its largest YoY loss of 8909.27% in 2025.
- Quarter analysis of 3 years shows OptimizeRx's Receivables Refunds stood at $1.0 million in 2023, then crashed by 93.82% to $64000.0 in 2024, then skyrocketed by 2629.69% to $1.7 million in 2025.
- Its last three reported values are $1.7 million in Q3 2025, $646000.0 for Q2 2025, and $113000.0 during Q1 2025.